AMARIN CORP PLC\UK(AMRN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

AMARIN CORP PLC\UK (AMRN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AMRN at 31.3/100 on a 32-signal composite quality model, placing it at rank #2,460 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (4.6) and profitability (21.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 21.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AMARIN CORP PLC\UK reports quarterly revenue of $42.2M, net income of $-7.7M. AMRN trades on the Nasdaq exchange and files with the SEC under CIK 897448. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMARIN CORP PLC\UK directly from SEC EDGAR.